Metabolic and bariatric surgery in patients with class I obesity; a two-year follow-up.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: BioMed Central Country of Publication: England NLM ID: 100968567 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2482 (Electronic) Linking ISSN: 14712482 NLM ISO Abbreviation: BMC Surg Subsets: MEDLINE
    • Publication Information:
      Original Publication: London : BioMed Central, [2001-
    • Subject Terms:
      Obesity, Morbid*/surgery ; Bariatric Surgery*/methods ; Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/surgery ; Hypertension*/complications ; Hypertension*/epidemiology ; Gastroesophageal Reflux*/complications ; Sleep Apnea, Obstructive*/complications ; Sleep Apnea, Obstructive*/surgery ; Dyslipidemias*/complications; Humans ; Female ; Adult ; Middle Aged ; Male ; Follow-Up Studies ; Obesity/complications ; Obesity/surgery ; Treatment Outcome ; Retrospective Studies
    • Abstract:
      Background: Patients with class I obesity may need metabolic and bariatric surgery (MBS) in the presence of obesity-associated medical problems, but MBS in this class of obesity is under debate. This study aimed to investigate the efficacy and safety of MBS in patients with class I obesity.
      Methods and Materials: This study was a historical cohort carried out on 112 patients with class I obesity with body mass index (BMI) of 30-35 kg/m 2 with a 24-month follow-up underwent MBS at Rasoul-e-Akram Hospital. The required data were extracted through the Iran National Obesity Surgery Database. The data required for the study consisted of demographic information such as age, gender, and obesity-associated medical problems like type-2 diabetes mellitus (T2DM), hypertension, obstructive sleep apnea, and dyslipidemia before surgery, 6, 12, and 24 months after surgery.
      Results: Mean age of the patients was 38.10 ± 10.04 years; mean BMI was 32.96 ± 1.35 kg/m 2 and 83.9% (n = 94) of patients were female. Out of 18 patients with T2DM, 11 patients (61.11%) had complete remission and seven patients (38.88%) had partial remission. Obstructive sleep apnea, hypertension, dyslipidemia, and gastroesophageal reflux disease were observed in 18 (16.07%), 23 (20.53%), 43 (38.39%), and 13 patients (11.60%) before surgery and resolved at 24-month follow-up. Post-operative complications during the 24-month follow-up were checked to assess safety and there were no De novo gastroesophageal reflux disease, intolerance, leakage, pulmonary thromboembolism, deep vein thrombosis, incisional hernia, hypoalbuminemia (Albumin < 3.5 g/dl), excessive weight loss (BMI < 18.5 kg/m 2 ) at any time during 24-months follow-ups and mortality. Early complications occurred as splenic injury in one case (0.89%), wound infection in one patient (0.89%), and extra-luminal bleeding in 10 (8.92%) after surgery, without any mortality.
      Conclusion: MBS is safe and effective in class I obesity and can be considered in selected patients with obesity-associated medical problems.
      (© 2023. The Author(s).)
    • References:
      Obes Surg. 2016 Mar;26(3):552-7. (PMID: 26189735)
      Surg Obes Relat Dis. 2023 Nov;19(11):1255-1262. (PMID: 37438232)
      Obes Surg. 2004 Mar;14(3):415-8. (PMID: 15072665)
      N Engl J Med. 2017 Feb 16;376(7):641-651. (PMID: 28199805)
      Obes Surg. 2018 Mar;28(3):649-655. (PMID: 28975492)
      Obes Surg. 2019 Jan;29(1):191-196. (PMID: 30238216)
      Obes Surg. 2013 Jun;23(6):809-18. (PMID: 23564465)
      Obes Surg. 2022 Jun;32(6):2083-2086. (PMID: 35303260)
      Obes Surg. 2021 Jun;31(6):2401-2409. (PMID: 33598844)
      Obes Surg. 2014 Oct;24(10):1670-8. (PMID: 24682804)
      Updates Surg. 2022 Aug;74(4):1399-1411. (PMID: 35779229)
      Bariatr Surg Pract Patient Care. 2021 Jun 1;16(2):85-91. (PMID: 34164238)
      Obes Surg. 2014 Apr;24(4):487-519. (PMID: 24638958)
      BMC Surg. 2023 Sep 9;23(1):272. (PMID: 37689633)
      Surg Obes Relat Dis. 2019 Apr;15(4):629-635. (PMID: 30858010)
      Consens Statement. 1991 Mar 25-27;9(1):1-20. (PMID: 1760489)
      Obes Surg. 2015 Apr;25(4):587-606. (PMID: 25802064)
      Obes Surg. 2023 Jan;33(1):3-14. (PMID: 36336720)
      JAMA Surg. 2015 Dec;150(12):1117-24. (PMID: 26374954)
      Am J Public Health. 2010 Jun;100(6):1019-28. (PMID: 20075322)
      World J Surg. 2015 Jan;39(1):223-30. (PMID: 25159119)
      Obes Surg. 2016 Aug;26(8):1659-96. (PMID: 27412673)
      Obes Surg. 2017 Dec;27(12):3267-3272. (PMID: 28601988)
      Prim Care. 2016 Mar;43(1):121-35, ix. (PMID: 26896205)
      Obes Surg. 2016 Jul;26(7):1457-62. (PMID: 26475028)
      Surg Obes Relat Dis. 2020 Feb;16(2):248-253. (PMID: 31831336)
      Surg Obes Relat Dis. 2018 Aug;14(8):1071-1087. (PMID: 30061070)
      Surg Obes Relat Dis. 2015 Sep-Oct;11(5):1127-32. (PMID: 26645489)
      Obes Surg. 2023 Oct;33(10):3051-3061. (PMID: 37561268)
      Can J Surg. 2022 Nov 16;65(6):E763-E769. (PMID: 36384687)
      Gastroenterol Res Pract. 2013;2013:276183. (PMID: 24454338)
      Obes Surg. 2015 May;25(5):824-9. (PMID: 25381478)
    • Contributed Indexing:
      Keywords: Bariatric Surgery; Low BMI; Metabolic Surgery; Obesity
    • Publication Date:
      Date Created: 20240103 Date Completed: 20240105 Latest Revision: 20240106
    • Publication Date:
      20240106
    • Accession Number:
      PMC10765846
    • Accession Number:
      10.1186/s12893-023-02295-x
    • Accession Number:
      38172751